Patients in ACA exchange plans have limited access to HIV drugs

Patients who are covered through Affordable Care Act exchange plans have more limited access to HIV drugs than those with other types of insurance, according to a new report from Avalere. Only 16 percent of silver-level exchange plans cover all of the top HIV drug regimens with cost-sharing of less than $100 per month, and though nearly half of exchange plans cover all 10 of the most commonly used regimens, many charge higher out-of-pocket costs for the drugs.

In addition, 30 percent of silver plans placed all 10 regimens on their highest tier, while employer plans placed single-source HIV medications on the specialty tier only 3 percent of the time, according to the report.

"Ensuring individuals living with HIV have affordable access to their medications is critical both for maintaining the health of the patient but also for improving public health by limiting disease transmission," Caroline Pearson, senior vice president at Avalere, said in the analysis. Report

Suggested Articles

In a huge win for hospitals, a federal judge has tossed the Trump administration's rule instituting site-neutral payments.

An estimated 73 million Americans with commercial health insurance face limited choices, according to a new American Medical Association study.

Absent adequate reimbursement for time spent on complex patient care, specialists are finding it harder to sustain their practices.